BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23532502)

  • 1. Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in chronic lymphocytic thyroiditis.
    Chui MH; Cassol CA; Asa SL; Mete O
    Virchows Arch; 2013 May; 462(5):557-63. PubMed ID: 23532502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
    Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
    Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
    Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular Epithelial Dysplasia as Hashimoto Thyroiditis-Related Atypia: a Series of 91 Specimens.
    Kholová I; Kalfert D; Lintusaari J; Rajakorpi E; Ludvíková M
    Endocr Pathol; 2021 Sep; 32(3):368-374. PubMed ID: 33991306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
    Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
    Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.
    Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS
    Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential.
    Nechifor-Boilă A; Cătană R; Loghin A; Radu TG; Borda A
    Rom J Morphol Embryol; 2014; 55(1):49-56. PubMed ID: 24715165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
    Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
    Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR; Gucer H
    Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 and PD-1 expression in thyroid follicular epithelial dysplasia: Hashimoto thyroiditis related atypia and potential papillary carcinoma precursor.
    Pakkanen E; Kalfert D; Ahtiainen M; Ludvíková M; Kuopio T; Kholová I
    APMIS; 2022 May; 130(5):276-283. PubMed ID: 35238073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis.
    Sargent R; LiVolsi V; Murphy J; Mantha G; Hunt JL
    Endocr Pathol; 2006; 17(3):235-41. PubMed ID: 17308360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
    Tong J; Wang Y; Da JP
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
    Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
    Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytologic features of focal papillary thyroid carcinoma arising within follicular adenoma: a masked cytomorphologic analysis of 17 cases.
    Ono JC; Wilbur DC; Lee H; Yang J; Krane JF; Bongiovanni M; Faquin WC
    Acta Cytol; 2011; 55(6):531-8. PubMed ID: 22156462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents.
    Iliadou PK; Effraimidis G; Konstantinos M; Grigorios P; Mitsakis P; Patakiouta F; Pazaitou-Panayiotou K
    Eur J Endocrinol; 2015 Dec; 173(6):827-33. PubMed ID: 26369577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma.
    Cameron BR; Berean KW
    J Otolaryngol; 2003 Oct; 32(5):319-22. PubMed ID: 14974863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid tumors of uncertain malignant potential: morphologic and imunohistochemical analysis of 29 cases.
    Nechifor-Boila A; Borda A; Sassolas G; Hafdi-Nejjari Z; Cătană R; Borson-Chazot F; Berger N; Decaussin-Petrucci M
    Pathol Res Pract; 2015 Apr; 211(4):320-5. PubMed ID: 25595997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.
    Coli A; Bigotti G; Parente P; Federico F; Castri F; Massi G
    J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.